Resources

3 Resources for

alzheimer's disease and patent

Elan and Wyeth Receive Patents Supporting Alzheimer's Disease Immunotherapy Treatments: DUBLIN, Ireland & MADISON, N.J. -- Seven new patents enhance the companies' patent portfolio in immunotherapy research and development; Tags: Alzheimer's disease, patent, Wyeth; Research articles 2004-09-22
Elan and Wyeth Receive Patents in Alzheimer's Immunotherapy; New patents further demonstrate the companies' leadership in immunotherapy research: DUBLIN, Ireland & MADISON, N.J. -- Elan Corporation, plc and Wyeth Pharmaceuticals, a division of Wyeth, today announced that the United States Patent and Trademark Office recently issued Neuralab Limited, a wholly owned subsidiary of Elan, three patents for the companies' joint research on immunotherapeutic approaches to the treatment of...; Tags: Alzheimer's disease, leadership, patent, Wyeth; Research articles 2004-07-14
Nymox Expands Large Patent Portfolio; Nymox Pharmaceutical -NASDAQ: NYMX- Has Several Hundred Patents and Applications Worldwide: MAYWOOD, N.J. -- A series of new patents add to the breadth and depth of the product development programs of Nymox Pharmaceutical Corporation (NASDAQ: NYMX), according the Company's General Counsel, Jack Gemmell. The Company was recently issued U.S. patents for a method of measuring cholesterol levels using saliva and for...; Tags: Alzheimer's disease, Company, Nasdaq Stock Market Inc., patent; Research articles 2005-02-23